LOGIN  |  REGISTER
Astria Therapeutics
Astria Therapeutics

Healthcare Triangle Awarded Contract Expansion with Fortune 500 Biopharmaceutical Customer

July 19, 2023 | Last Trade: US$0.74 0.04 -4.85

PLEASANTON, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, and data analytics for the healthcare and life sciences industries, today announced that it has secured a multi-year program expansion contract with a top-five customer, a Fortune 500 biopharmaceutical company. The agreement extends the customer’s suite of cloud DevOps, data engineering, and data platform management solutions.

“Over the past four years of this client’s program, HCTI has developed a high performance computing (HPC) environment supported by a custom deployment of DataEz, our HITRUST-certified, fully managed AI engineering and analytics platform-as-a-service. This new agreement renews and expands our managed services engagement, reinforcing our value as a trusted advisor and a highly-engaged business partner,” said Lena Kannappan, head of business, strategy and partnerships for Healthcare Triangle. “Our expertise in challenging the status quo, providing strategic alternatives, and implementing creative, novel solutions in cloud transformation and cloud acceleration for pharmaceutical and life sciences organizations enabled us to broaden our range of services for this program. We are thrilled to continue this highly valued client relationship.”

Healthcare Triangle advances industry-transforming solutions in the areas of cloud services, data science, cyber security and professional and managed services for the healthcare and life sciences industries. The Company is strategically partnered with leading public cloud providers including Amazon Web Services, Google Cloud, Microsoft Azure Cloud, and EHR vendors.

About Healthcare Triangle

Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz and DataEz. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit www.healthcaretriangle.com.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Prospectus filed with the SEC on October 7, 2021, previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

Contacts

Media:
Michael Campana
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investors:
1-800-617-9550
This email address is being protected from spambots. You need JavaScript enabled to view it.

C4 Therapeutics

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB